[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.150.57. Please contact the publisher to request reinstatement.
Editorial
August 2017

Generic Drugs—Changes in Cost and Challenges in Practice

Author Affiliations
  • 1Department of Dermatology, Penn State Hershey Medical Cancer, Hershey, Pennsylvania
JAMA Dermatol. 2017;153(8):745-746. doi:10.1001/jamadermatol.2017.1129

To do nothing is within the power of all (wo)men.

Samuel Johnson

One of our patients is a woman in her 80s, on Medicare, who has newly diagnosed psoriasis, macular degeneration, and insulin-dependent diabetes. Her current medication expenses account for 25% of her fixed monthly income of less than $2500. She is in the “donut hole,” the point at which she pays a larger share of drug costs. The prescribed 60-g tube of generic clobetasol propionate, 0.05%, cream was $447, and she was responsible for 51% of the cost. She decided to forego treatment because she could not afford the additional $227 expense.

×